Prostate cancer screening pilot program
1 paper2 findings
- 1 lab in 1 country
- Funders: European Commission and 2 more
- Human trial1
Outcomes
22-yr PSA testing rate
upin humans1
1 study
2-yr PSA testing rate
upin humans1
Prostate cancer screening pilot program increases 2-yr PSA testing rate in humans (from 47.4% to 53.3%).
“From 2023 to 2024, the 2-yr PSA testing rate rose from 47.4% to 53.3%”
Human trialorganized screening pilot program12 momalesn = 150,498
Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Program
European urology open science25 Jul 2026
Prebiopsy MRI use
upin humans1
1 study
Prebiopsy MRI use
upin humans1
Prostate cancer screening pilot program increases prebiopsy MRI use in humans (10.3 percentage-point difference, 95% CI 8.3-12.2).
“prebiopsy MRI use increased from 28.0% to 38.3% (10.3 percentage-point difference, 95% confidence interval 8.3-12.2)”
Human trialorganized screening pilot program12 momalesn = 150,498
Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Program
European urology open science25 Jul 2026
Latest
1 in 12 monthsEuropean Urology Open Science
Implementation and First Results of the Czech Nationwide Prostate Cancer Screening Pilot Program
Non-randomised trial in 150,498 peopleProstate cancer